The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Thalidomide, sold under the brand name?Thalomid?among others, is a medication used to treat a number of cancers including multiple myeloma, graft-versus-host disease, and a number of skin conditions including complications of leprosy.
The global Thalomid market was valued at US$ 523 million in 2023 and is anticipated to reach US$ 1004.5 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
Thalomid (generic name: thalidomide) is a pharmaceutical drug that was initially developed as a sedative and anti-nausea medication in the late 1950s and early 1960s. However, it gained notoriety due to its severe teratogenic effects, causing birth defects in children born to mothers who took the drug during pregnancy. Thalidomide was subsequently withdrawn from the market in many countries.
This report aims to provide a comprehensive presentation of the global market for Thalomid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thalomid.
Report Scope
The Thalomid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thalomid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thalomid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Segment by Type
50mg
100mg
200mg
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thalomid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thalomid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Thalidomide, sold under the brand name?Thalomid?among others, is a medication used to treat a number of cancers including multiple myeloma, graft-versus-host disease, and a number of skin conditions including complications of leprosy.
The global Thalomid market was valued at US$ 523 million in 2023 and is anticipated to reach US$ 1004.5 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
Thalomid (generic name: thalidomide) is a pharmaceutical drug that was initially developed as a sedative and anti-nausea medication in the late 1950s and early 1960s. However, it gained notoriety due to its severe teratogenic effects, causing birth defects in children born to mothers who took the drug during pregnancy. Thalidomide was subsequently withdrawn from the market in many countries.
This report aims to provide a comprehensive presentation of the global market for Thalomid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thalomid.
Report Scope
The Thalomid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thalomid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thalomid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Celgene
Segment by Type
50mg
100mg
200mg
Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thalomid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thalomid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Thalomid Market Overview
1.1 Product Overview and Scope of Thalomid
1.2 Thalomid Segment by Type
1.2.1 Global Thalomid Market Value Comparison by Type (2024-2030)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.3 Thalomid Segment by Application
1.3.1 Global Thalomid Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Other
1.4 Global Thalomid Market Size Estimates and Forecasts
1.4.1 Global Thalomid Revenue 2019-2030
1.4.2 Global Thalomid Sales 2019-2030
1.4.3 Global Thalomid Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Thalomid Market Competition by Manufacturers
2.1 Global Thalomid Sales Market Share by Manufacturers (2019-2024)
2.2 Global Thalomid Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Thalomid Average Price by Manufacturers (2019-2024)
2.4 Global Thalomid Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Thalomid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thalomid, Product Type & Application
2.7 Thalomid Market Competitive Situation and Trends
2.7.1 Thalomid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thalomid Players Market Share by Revenue
2.7.3 Global Thalomid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thalomid Retrospective Market Scenario by Region
3.1 Global Thalomid Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Thalomid Global Thalomid Sales by Region: 2019-2030
3.2.1 Global Thalomid Sales by Region: 2019-2024
3.2.2 Global Thalomid Sales by Region: 2025-2030
3.3 Global Thalomid Global Thalomid Revenue by Region: 2019-2030
3.3.1 Global Thalomid Revenue by Region: 2019-2024
3.3.2 Global Thalomid Revenue by Region: 2025-2030
3.4 North America Thalomid Market Facts & Figures by Country
3.4.1 North America Thalomid Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Thalomid Sales by Country (2019-2030)
3.4.3 North America Thalomid Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Thalomid Market Facts & Figures by Country
3.5.1 Europe Thalomid Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Thalomid Sales by Country (2019-2030)
3.5.3 Europe Thalomid Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thalomid Market Facts & Figures by Country
3.6.1 Asia Pacific Thalomid Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Thalomid Sales by Country (2019-2030)
3.6.3 Asia Pacific Thalomid Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Thalomid Market Facts & Figures by Country
3.7.1 Latin America Thalomid Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Thalomid Sales by Country (2019-2030)
3.7.3 Latin America Thalomid Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thalomid Market Facts & Figures by Country
3.8.1 Middle East and Africa Thalomid Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Thalomid Sales by Country (2019-2030)
3.8.3 Middle East and Africa Thalomid Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Thalomid Sales by Type (2019-2030)
4.1.1 Global Thalomid Sales by Type (2019-2024)
4.1.2 Global Thalomid Sales by Type (2025-2030)
4.1.3 Global Thalomid Sales Market Share by Type (2019-2030)
4.2 Global Thalomid Revenue by Type (2019-2030)
4.2.1 Global Thalomid Revenue by Type (2019-2024)
4.2.2 Global Thalomid Revenue by Type (2025-2030)
4.2.3 Global Thalomid Revenue Market Share by Type (2019-2030)
4.3 Global Thalomid Price by Type (2019-2030)
5 Segment by Application
5.1 Global Thalomid Sales by Application (2019-2030)
5.1.1 Global Thalomid Sales by Application (2019-2024)
5.1.2 Global Thalomid Sales by Application (2025-2030)
5.1.3 Global Thalomid Sales Market Share by Application (2019-2030)
5.2 Global Thalomid Revenue by Application (2019-2030)
5.2.1 Global Thalomid Revenue by Application (2019-2024)
5.2.2 Global Thalomid Revenue by Application (2025-2030)
5.2.3 Global Thalomid Revenue Market Share by Application (2019-2030)
5.3 Global Thalomid Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Celgene
6.1.1 Celgene Corporation Information
6.1.2 Celgene Description and Business Overview
6.1.3 Celgene Thalomid Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Celgene Thalomid Product Portfolio
6.1.5 Celgene Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thalomid Industry Chain Analysis
7.2 Thalomid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thalomid Production Mode & Process
7.4 Thalomid Sales and Marketing
7.4.1 Thalomid Sales Channels
7.4.2 Thalomid Distributors
7.5 Thalomid Customers
8 Thalomid Market Dynamics
8.1 Thalomid Industry Trends
8.2 Thalomid Market Drivers
8.3 Thalomid Market Challenges
8.4 Thalomid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
